MedPath
NMPA Approval

Budesonide Suspension for Inhalation

国药准字H20244102

June 18, 2024

Drug Information

吸入用布地奈德混悬液

吸入制剂

2ml:1mg

化学药品

June 18, 2024

Company Information

Applicant Company

南京市江北新区星晖路71号加速器六期9栋

Manufacturing Company

南京市江北新区星晖路71号加速器六期9栋

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用布地奈德混悬液 - NMPA 批准文号 | MedPath